Copyright: ©Author(s) 2026.
World J Hepatol. Jul 27, 2026; 18(7): 121954
Published online Jul 27, 2026. doi: 10.4254/wjh.121954
Published online Jul 27, 2026. doi: 10.4254/wjh.121954
Table 3 Docking information between key components and core targets
| No. | Target | Component | Binding energy (kcal/mol) |
| 1 | HAO1 | Dehydrotrametenonic acid | -19.8 |
| 2 | 16α-Hydroxydehydrotrametenolic acid | -18.9 | |
| 3 | Glycyrrhetinic acid | -18.9 | |
| 4 | TYMS | Dehydropachymic acid | -9.1 |
| 5 | DHODH | Dehydrotrametenonic acid | -6.2 |
| 6 | AKR1B1 | Liquiritigenin | -5.6 |
| 7 | Liquiritin | -6.9 | |
| 8 | Chlorogenic acid | -6.5 | |
| 9 | AKR1B10 | Dehydrotrametenonic acid | -7.2 |
| 10 | Glabrolide | -7.3 | |
| 11 | Poricoic acid A | -5.8 | |
| 12 | 16α-hydroxydehydrotrametenolic acid | -6.8 | |
| 13 | Glycyrrhetinic acid | -6.7 | |
| 14 | Chlorogenic acid | -6.3 | |
| 15 | AKR1A1 | Glabrol | -8.9 |
| 16 | GUSB | 4-shogaol | -6.9 |
| 17 | PYGM | Glabrolide | -9 |
| 18 | ALDH5A1 | 7-hydroxycoumarin | -6.4 |
| 19 | PIK3CA | Alisol F | -7.1 |
| 20 | Liquiritigenin | -5.8 | |
| 21 | PIK3CD | Alisol F | -9.2 |
| 22 | Glabrol | -7.8 | |
| 23 | 4-Shogaol | -7 | |
| 24 | (10)-Gingerol | -6.5 | |
| 25 | Gingerenone A | -7.1 | |
| 26 | Ligustilide | -6.9 | |
| 27 | Phenethyl benzoate | -7 | |
| 28 | PLCG1 | Dehydropachymic acid | -7.2 |
| 29 | 1-Dehydro-[10]-gingerdione | -5 | |
| 30 | PIK3CG | Glabrol | -9.1 |
| 31 | 1-Dehydro-[10]-gingerdione | -6.7 | |
| 32 | 4-Shogaol | -7.1 | |
| 33 | Gingerenone A | -7.8 | |
| 34 | PIK3CB | Alisol F | -9.5 |
| 35 | Liquiritigenin | -7.5 | |
| 36 | 4-Shogaol | -6 | |
| 37 | (10)-Gingerol | -5.3 | |
| 38 | Gingerenone A | -6.4 | |
| 39 | PI4KB | 4-Shogaol | -6.3 |
| 40 | ACP1 | Poricoic acid A | -7.7 |
| 41 | 16α-hydroxydehydrotrametenolic acid | -7.6 |
- Citation: Tao YX, Gong DH, Yang H, Wang PQ, Tang YM, Zhou QD, Wang YY, Zhang Y, Chen WD, Yu J, Yang XX. Poria in Fuling Zexie decoction for treating metabolic dysfunction-associated steatotic liver disease: Underlying mechanisms and key bioactive substances. World J Hepatol 2026; 18(7): 121954
- URL: https://www.wjgnet.com/1948-5182/full/v18/i7/121954.htm
- DOI: https://dx.doi.org/10.4254/wjh.121954